Product NDC: | 52584-754 |
Proprietary Name: | Magnesium Sulfate |
Non Proprietary Name: | Magnesium Sulfate Heptahydrate |
Active Ingredient(s): | 5 g/10mL & nbsp; Magnesium Sulfate Heptahydrate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52584-754 |
Labeler Name: | General Injectables & Vaccines, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075151 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100801 |
Package NDC: | 52584-754-10 |
Package Description: | 1 SYRINGE, PLASTIC in 1 BAG (52584-754-10) > 10 mL in 1 SYRINGE, PLASTIC |
NDC Code | 52584-754-10 |
Proprietary Name | Magnesium Sulfate |
Package Description | 1 SYRINGE, PLASTIC in 1 BAG (52584-754-10) > 10 mL in 1 SYRINGE, PLASTIC |
Product NDC | 52584-754 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Magnesium Sulfate Heptahydrate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20100801 |
Marketing Category Name | ANDA |
Labeler Name | General Injectables & Vaccines, Inc |
Substance Name | MAGNESIUM SULFATE HEPTAHYDRATE |
Strength Number | 5 |
Strength Unit | g/10mL |
Pharmaceutical Classes | Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA] |